References
- W Hong. Shortage of GLP-1 Injections Causes Concern in the Field... When Will It Be Resolved? [Internet]. Doctors News. 2023 [cited 2024 Jun 15]; Available from: https://www.doctorsnews.co.kr/news/articleView.html?idxno=150988
- Department of Health & Social Care. National Patient Safety Alert: shortage of GLP-1 receptor agonists [Internet]. Department of Health & Social Care, National Health Service England. 2023 [cited 2024 Jun 15]; Available from: https://www.cas.mhra.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=103235
- Department of Health & Social Care. National Patient Safety Alert: shortage of GLP-1 receptor agonists (GLP-1 RA) update [Internet]. Department of Health & Social Care, National Health Service England. 2024 [cited 2024 Jun 15]; Available from: https://www.pslhub.org/learn/improving-patient-safety/patient-safety-alerts/uk/national-patient-safety-alert-shortag-eof-glp-1-receptor-agonists-glp-1-ra-update-3-january-2024-r10864/
- World Health Organization (WHO). Shortages impacting access to glucagon-like peptide 1 receptor agonist products; increasing the potential for falsified versions [Internet]. WHO. 2024 [cited 2024 Jun 15]; Available from: https://www.who.int/news/item/29-01-2024-shortages-impacting-access-to-glucagon-like-peptide-1-receptor-agonist-products--increasing-the-potential-for-falsified-versions
- Whitley HP, Trujillo JM, Neumiller JJ. Special report: potential strategies for addressing GLP-1 and dual GLP-1/GIP receptor agonist shortages. Clin Diabetes 2023;41:467-73.